CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
In a company statement, Des Speed, chief executive of PathXL, said, “By removing the [manual marking] bottleneck and delivering greater levels of accuracy, we can help accelerate drug development and the detection and analysis of cancerous tissue.”
PathXL, +44 (0) 7702 684290
Pages: 1 2